[1]
2023. EVALUATING LACTOBACILLUS CASEI PROBIOTIC EFFICACY IN MILD TO MODERATE ULCERATIVE COLITIS: A PLACEBO-CONTROLLED INVESTIGATION. International journal of medical sciences. 3, 04 (Apr. 2023), 01–04.